arrow
H

Hannah Y. Wen

Memorial Sloan Kettering Cancer Center
H指数:40
被引数:6,494

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Molecular risk stratification for decision-making among patients with breast cancer eligible to omit radiotherapy.

乳腺癌患者中,针对可免于放疗患者的分子风险分层以辅助决策制定。

2026-03-250
PRE
A Worldwide Survey on Pathological Measurement of Residual Breast Cancer After Neoadjuvant Therapy: Different Interpretations of the ypTNM Classification
2026-01-220
OAAI
International Expert Consensus Recommendations for HER2 Reporting in Breast Cancer: Focus on HER2-low and Ultralow Categories

国际专家共识建议:乳腺癌HER2报告,重点关注HER2-low和Ultralow类别

2025-10-280
OAAI
Breast carcinomas associated with microglandular adenosis are linked to germline alterations in homologous recombination-deficiency genes

与微腺体腺病相关的乳腺癌与同源重组缺陷基因的胚系改变有关

2025-07-220
OAAI
Malignant phyllodes tumours of the breast: the case for revising WHO's 'full house' diagnostic criteria

乳腺恶性叶状肿瘤:修订世界卫生组织“全垒打”诊断标准的必要性

2025-04-010
OAAI